Transplant Glomerulopathy May Occur in the Absence of Donor-Specific Antibody and C4d Staining
Author(s) -
Enver Akalin,
Rajani Dinavahi,
Steven Dikman,
Graciela de Boccardo,
Rex Friedlander,
Bernd Schröppel,
Vinita Sehgal,
Jonathan S. Bromberg,
Peter S. Heeger,
Barbara Murphy
Publication year - 2007
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.02420607
Subject(s) - medicine , staining , glomerulopathy , proteinuria , nephropathy , biopsy , antibody , gastroenterology , transplantation , creatinine , urology , kidney transplantation , pathology , kidney , immunology , endocrinology , diabetes mellitus
Transplant glomerulopathy (TGP) has been proposed to be a component of chronic antibody-mediated rejection (AMR). We have studied 36 patients with TGP and 51 patients with chronic allograft nephropathy (CAN) but without TGP for C4d staining and donor-specific anti-HLA antibodies (DSA) to investigate the alloantibody-mediated mechanisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom